Anixa Biosciences (ANIX) EBITDA Margin (QoQ) (2010 - 2018)
Anixa Biosciences (ANIX) EBITDA Margin (QoQ) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Anixa Biosciences | 124.29 Mn | 124.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2018 | -135,963.00 |
| Oct 31, 2016 | 51,823.00 |
| Jul 31, 2015 | 696,377.00 |
| Apr 30, 2015 | -857,517.00 |
| Jan 31, 2015 | 15,600.00 |
| Oct 31, 2014 | -10,034.00 |
| Oct 31, 2012 | -49.28 Mn |
| Jul 31, 2012 | 9,613.00 |
| Apr 30, 2012 | -15,649.00 |
| Jan 31, 2012 | 2,676.00 |
| Oct 31, 2011 | 4,388.00 |
| Jul 31, 2011 | 121,324.00 |
| Apr 30, 2011 | 751,812.00 |
| Jan 31, 2011 | -863,744.00 |
| Oct 31, 2010 | 182,689.00 |